New combo changes colon cancer
49:20–50:33 · 73s
Dr. Swisher highlights promising advances: GLP-1s, AI-driven drug discovery, and especially adding atezolizumab to standard FOLFOX, which he says is "radically" improving outcomes.
49:20–50:33 · 73s
Dr. Swisher highlights promising advances: GLP-1s, AI-driven drug discovery, and especially adding atezolizumab to standard FOLFOX, which he says is "radically" improving outcomes.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.